Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

SABCS 2021

SABCS 2021: Subgroup analysis of trastuzumab deruxtecan shows ‘encouraging’ results in controlling stable brain metastases in HER2-positive metastatic breast cancer

SABCS 2021: Subgroup analysis of trastuzumab deruxtecan shows ‘encouraging’ results in controlling stable brain...

SABCS 2021: Black women are more likely to develop lymphedema following breast cancer treatment than white women

SABCS 2021: Black women are more likely to develop lymphedema following breast cancer treatment than white women

SABCS 2021: Tamoxifen may boost PI3K signalling to increase uterine cancer risk in patients with breast cancer

SABCS 2021: Tamoxifen may boost PI3K signalling to increase uterine cancer risk in patients with breast cancer

SABCS 2021: Breast cancer patients with oestrogen receptor mutations may benefit from early switch to fulvestrant/palbociclib

SABCS 2021: Breast cancer patients with oestrogen receptor mutations may benefit from early switch to fulvestrant...

SABCS 2021: Single-cell spatial analysis may help predict response to neoadjuvant immunotherapy in triple-negative breast cancer

SABCS 2021: Single-cell spatial analysis may help predict response to neoadjuvant immunotherapy in triple-negative...

SABCS 2021: Tamoxifen may boost PI3K signalling to increase uterine cancer risk in patients with breast cancer

SABCS 2021: Tamoxifen may boost PI3K signalling to increase uterine cancer risk in patients with breast cancer

SABCS 2021: Elacestrant may improve outcomes for patients whose metastatic breast cancers progressed on prior endocrine therapy

SABCS 2021: Elacestrant may improve outcomes for patients whose metastatic breast cancers progressed on prior...

SABCS 2021: Investigational therapy pyrotinib with chemotherapy may improve outcomes in patients with pretreated HER2-positive breast cancer

SABCS 2021: Investigational therapy pyrotinib with chemotherapy may improve outcomes in patients with pretreated...

SABCS 2021: Using genomics to match treatments improved outcomes for certain patients with metastatic breast cancer

SABCS 2021: Using genomics to match treatments improved outcomes for certain patients with metastatic breast cancer

More from ecancer